Tofacitinib Helps in Ulcerative Colitis (CME/CE)

(MedPage Today) — The oral JAK inhibitor tofacitinib, currently under FDA review for treating rheumatoid arthritis, also showed promise for ulcerative colitis in a randomized trial.

Post a Comment

Comments are closed.